Section Arrow
RNA.NASDAQ
- Avidity Biosciences
Quotes are at least 15-min delayed:2024/12/23 22:16 EST
Last
 31.64
-0.18 (-0.57%)
Day High 
32.16 
Prev. Close
31.82 
1-M High
45.98 
Volume 
1.32M 
Bid
31.64
Ask
32.38
Day Low
30.91 
Open
31.32 
1-M Low
30.07 
Market Cap 
3.80B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 33.45 
20-SMA 37.29 
50-SMA 42.44 
52-W High 56 
52-W Low 8.86 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.88/-2.90
Enterprise Value
3.80B
Balance Sheet
Book Value Per Share
12.60
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
9.56M
Operating Revenue Per Share
0.08
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TNXPTonix Pharmaceuticals Holding Corp.0.4031-0.2085-34.09%-- 
RAPTRAPT Therapeutics1.74+0.9146+110.81%-- 
TRAWTraws Pharma Inc12.57+7.55+150.40%-- 
CEROCERo Therapeutics Holdings0.0505-0.0056-9.98%-- 
RXRXRecursion Pharmaceuticals6.99+0.96+15.92%-- 
Quotes are at least 15-min delayed:2024/12/23 22:16 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.